TRX Gold CEO Stephen Mullowney joined Steve Darling from Proactive to share news the company has put out its Q2 financial numbers that continues to show the trend of record revenue as the new ball mill at Buckreef Gold has been running smoothly.

Mullowney telling Proactive that ball mill, which is providing 1000 plus tonnes a day in production, helped the company record its highest quarterly production to date of 5,636 ounces of gold and sold 5,505 ounces of gold. The company also saw recognized revenue of 19.8 million with costs of sales of $9.6 million which amounted gross profit of 10.2 million dollars.

The company also announced they have drilled 13 holes representing 1,411 meters at Buckreef including exploration drilling at the Eastern Porphyry area and sterilization drilling at Buckreef Gold’s ROM pad.

#proactiveinvestors #trxgoldcoorporation #tsx #tnx #nyseamercian #trx #mining #gold

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Star Navigations Systems Group CEO Anoop Brar joined Steve Darling from Proactive to share news about the company that provides In-flight Safety Monitoring Systems, including STAR-ISMS. The company provides real-time capability of tracking, performance trends and predicting incident-occurrences to increase flight safety.

Brar share with Proactive the company has agreed to a re-seller agreement with Ottawa based APS Aerospace Corp. The deal will provide a complete end-to-end ecosystem of in-flight and post-flight analysis

#proactiveinvestors #starnavigationsystemsgroupltd #cse #sna #airplanes #airlinesafety

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to share news the company has received a Notice of Allowance for a patent around its work chronic kidney disease.

Moreau telling Proactive the patent, which is titled “Compositions and Methods for Treating Non-Alcoholic Steatohepatitis”, is based around its kidney disease program with the drug NP-251 or Repirinast. This is the company’s first allowance notice received from the US patent office.

#proactiveinvestors #algernonpharmaceuticals #cse #otcqb #ifenprodil #pharma

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Sintana Energy President Robert Bose joins Natalie Stoberman from the Proactive studios to share the company's gas and oil exploration strategy at its Colombia and Namibia targets.

Sintana Energy is engaged in petroleum and natural gas exploration and development activities in Colombia’s Magdalena Basin and five large, highly prospective, onshore and offshore petroleum exploration licenses in Namibia. Sintana’s exploration strategy is to acquire, explore, develop and produce superior quality assets with substantial reserves potential.

#proactiveinvestors #sintanaenergy #TSX #SEI #OTCQB #SEUSF #oilandgas #petroleumexploration #naturalgas #acquisitionstrategy #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Downing Renewables & Infrastructure Trust (LSE:DORE) PLC manager Tom Williams joins Proactive London to give a progress update, following the release of its annual report for 2022.

Williams says that the diversification strategy the trust has been pursuing "is really working", and highlights the achievement in 2022 of a 19.5% total return, against a target of between 6.6-7.5%.

#ProactiveInvestors #DORE #Downing #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Givex CEO Don Gray joins Natalie Stoberman from the Proactive newsroom to discuss the company's fiscal year and fourth quarter 2022 financial results.

Gray says Givex has achieved a 2022 total revenue increase of $17.7 million from $55.2 million to $72.9 million, accounting for 32 percent in growth. Grays adds that the company's fourth quarter closed the year with a strong performance marked by 40 percent growth and a $6.1 million revenue increase.

Givex provides merchants with customer engagement, point of sale and payment solutions, all in a single platform. We are integrated with 1000+ technology partners, creating a fully end-to-end solution that delivers powerful customer insights. Our platform is used by some of the world’s largest brands, comprising approximately 122,000 locations across more than 100 countries.

#proactiveinvestors #givex #TSX #GIVX #OTCQX #GIVXF #giftcards #pointofsale #earnings #fiscalyear #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Proactive Research Analyst, Manos Halicioglu speaks about his new research report into Sirius Real Estate Limited, a company that provides small and medium-sized businesses with flexible workspaces in Germany and the UK.

The company's unique business model allows it to significantly enhance returns and reduce risk by converting structural vacancy into high-demand workspaces based on proprietary data generated through its in-house marketing platform.

Read the full report by clicking on the link in the video:

https://www.proactiveinvestors.co.uk/companies/news/1012304/sirius-real-estate-a-unique-opportunity-with-a-medium-risk-return-profile-1012304.html

#ProactiveInvestors #SiriusRealEstate #RealEstateInvesting #Workspaces #SmallBusiness #MediumBusiness #IndustrialSpaces #FlexibleWorkspaces #InvestmentOpportunity #FinancialReport #StockMarket #LondonStockExchange #JohannesburgStockExchange #ProprietaryData #Productivity #MaximizingProfits #RiskReduction #Diversification #ProvenTrackRecord #ShareholderReturns #MediumRisk #InvestmentReturns #DiscountedCashFlow #FreeCashFlowValuation #Beta #MarketAnalysis #FinancialAnalysis #ProactiveResearch #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Mosman Oil and Gas Ltd (AIM:MSMN) chairman John W Barr speaks to Thomas Warner from Proactive after announcing a successful workover of its historic G1 well at Cinnabar, Texas, which he says has not been artificially lifted or injected with water or gas since its production in the 1980s.

The company is also reviewing proposals to "drive value" into its two operating segments, Australian exploration projects and US production and development, with the involvement of ex-CEO of Helium One, David Minchin.

#ProactiveInvestors #MosmanOilandGas #CinnabarWell #TexasOilProduction #OilandGasIndustry #Drilling #Production #EnergySector #OilExploration #GasCompressor #ValueCreation #InvestmentOpportunities #USOilProduction #AustralianExploration #HeliumOne #DavidMinchin #Proactiv #OilandGasInvestment #OilPrices #EnergyMarket #OilandGasUpdates #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Good morning from London, where the FTSE 100 is at fresh five week highs this morning after a flurry of US bank results last week suggested that the markets may now be starting to settle down after the collapse of Silicon Valley Bank.

But settling down isn’t the same as flourishing, and Barclays has announced this morning that its cutting over 100 investment banking roles over the coming weeks in response to the general slowdown in global stock market activity.

Into those stock markets now, and shares in defence group QinetiQ are up after it announced less than a month into its new financial year that it expects to surpass previous guidance.

Oil and gas engineering firm Wood Group said it will engage with prospective buyer Apollo Management so a firm offer can be made after it rejected a fourth bid from the asset manager in early March.

US pharma company Merck & Co. is set to acquire Prometheus Biosciences for US$10.8bn, as it looks to bolster pipeline projects.

And in small caps, Eden Research stocks are up this morning on news that its flagship pesticide has received regulatory approval in Poland.

#ProactiveInvestors #FTSE100 #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Patrys Ltd (ASX:PAB) managing director and CEO Dr James Campbell talks with Proactive’s Elisha Newell about two new patents that advance protection for the company’s antibody technology through to 2039. The first patent, co-filed with Yale University, is the first US patent to be granted specifically for PAT-DX1 and PAT-DX3, while the second covers deoxymabs with nanocarriers — a combination that could provide a powerful new approach for treating cancer. Dr Campbell highlights the growing opportunity in the cancer therapeutics space and says Patrys looks forward to its first-in-human clinical trial for PAT-DX1 next year.

#ProactiveInvestors #Patrys #ASX #Oncology #Patents #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews